← Evidence map

ArticleEMBO molecular medicine2022

Clinical grade ACE2 as a universal agent to block SARS-CoV-2 variants.

Vanessa Monteil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

35 papers cite it

2022
2023
2024
2025
2026
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 35781796